Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Pfizer Ltd.
NSE: PFIZER
|
BSE: 500680
|
ISIN: INE182A01018
|
Industry: Pharmaceuticals
|
Mid-range Performer
5669.0000
-182.00
(
-3.11
%)
NSE
Jul 09, 2025
15:31 PM
53.17% Gain from 52W Low
Volume:
62,010
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Pfizer Ltd.
edited
02 Dec 2020
5669.00
-3.11%
Pfizer-BioNTech's Covid-19 vaccine gets EUA for use in UK
Business Line
Still a long shot for India, given its distribution challenges
Pfizer Ltd. is trading
below its 30 day SMA
of 5721.2
UK approves Pfizer's COVID-19 vaccine: When will it come to India and all other questions answered
Moneycontrol |
02 Dec 2020
9 more
Pfizer share climbs 5% after UK approves COVID-19 vaccine
Business Today |
02 Dec 2020
UK OKs Pfizer-BioNTech Vaccine For Use In Global First
NDTV Profit |
02 Dec 2020
Pfizer shares jump over 5% on reports of UK authorising its COVID-19 vaccine
Moneycontrol |
02 Dec 2020
UK approves Pfizer-BioNTech Covid vaccine; to be available from next week
Business Standard |
02 Dec 2020
UK approves Pfizer-BioNTech vaccine for use
Business Line |
02 Dec 2020
UK approves Pfizer-BioNTech COVID-19 vaccine; rollout to begin next week
Moneycontrol |
02 Dec 2020
Breaking: UK becomes first country to approve Pfizer & BioNTech vaccine for mass use
Business Today |
02 Dec 2020
Mexico set to sign deal with Pfizer for delivery of Covid-19 vaccine
Business Standard |
02 Dec 2020
Letters to the editor dated December 2, 2020
Business Line |
02 Dec 2020
More from Pfizer Ltd.
Recommended
Market closes lower, Sarda Energy gets CSPDCL nod to source power from Rehar-1 hydro project
Trendlyne Marketwatch |
09 Jul 2025, 05:47PM
All in the family: Bajaj, Murugappa, Mahindra & Tata Group stocks outpace the benchmark
The Baseline |
09 Jul 2025, 04:24PM
Earnings Call Transcript - Pfizer
|
04 Feb 2020